People: Targacept Inc (TRGT.O)
6 Dec 2013
Ms. Julia R. Brown is an Independent Director of Targacept, Inc., since November 2007. From January 2000 until her retirement in September 2008, Ms. Brown was affiliated with Amylin Pharmaceuticals, Inc., a biopharmaceutical company, serving as executive vice president until July 2003 and then as an adviser to the chief executive officer. She is chairman of the board of trustees of the University of California San Diego Foundation. In 2010, Ms. Brown received an award for “Distinguished Contribution to the Life Science Industry” from CONNECT, an organization that fosters innovation and the formation of new technology companies in southern California and for which she serves as a director. Within the past five years, she served on the board of directors of each of the publicly-traded companies Labopharm, Inc. (acquired by Palatin Labs Inc.) and Tanox, Inc. (acquired by Genentech, Inc.).
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|